Thank you for taking action! Got one more minute? 

Like so much else, when the coronavirus pandemic hit, medical research and clinical trials, including those for cancer, ground to a halt. Will you ask your U.S. Senators to include funding in the next coronavirus relief package to restart medical research and clinical trials? Cancer patients can't wait.


  • Your Senators


*Required fields
  Congress requires a phone number in order to submit your comments.


Dear [Decision Maker],

As a volunteer for the American Cancer Society Cancer Action Network (ACS CAN), I am writing to you regarding the impact of COVID-19 on the cancer research ecosystem. COVID-19 has meant that vital research and clinical trials across the country are stalled. Funding is needed to ensure that labs and researchers can restart their operations when it is safe to do so. In the next COVID-19 emergency response package, I ask that the Senate include at least $10 billion for the National Institutes of Health (NIH) in order to re-open labs and re-start clinical trials. Without this funding, we are in danger of losing some of the progress we have made in the fight against cancer.

Substantial costs have been incurred for the shut-down, and there will be significant costs for the eventual ramp-up of research activities. I therefore urge Congress to provide the NIH with at least $10 billion to ensure the research ecosystem is restored progress continues in the fight against cancer and other diseases.

[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]